Clinically, YAP1 and TAZ can be used as diagnostic and prognostic tools values as their upregulation is not only responsible for early tumor detection but also predicts a worse prognosis in patients suffering from GI cancers [76,114]. The gene discussed is WWTR1; the disease is neoplasm.